Source:http://linkedlifedata.com/resource/pubmed/id/15353981
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
14
|
pubmed:dateCreated |
2004-9-8
|
pubmed:abstractText |
In HIV-1-infected patients with long-term undetectable viraemia on highly active antiretroviral treatment (HAART), we found that pre-HAART plasma viraemia and the baseline proviral DNA level were significantly associated with the viraemia setpoint during scheduled treatment interruptions. In long-term treated patients, pre-HAART viraemia may not be available, and in these circumstances proviral DNA, measured at the time of scheduled treatment interruption, can help to identify patients likely to reach a low viraemia setpoint after treatment interruption.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0269-9370
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
24
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1951-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15353981-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15353981-Cohort Studies,
pubmed-meshheading:15353981-DNA, Viral,
pubmed-meshheading:15353981-HIV Infections,
pubmed-meshheading:15353981-HIV-1,
pubmed-meshheading:15353981-Humans,
pubmed-meshheading:15353981-Multivariate Analysis,
pubmed-meshheading:15353981-Mutation,
pubmed-meshheading:15353981-RNA, Viral,
pubmed-meshheading:15353981-Viremia
|
pubmed:year |
2004
|
pubmed:articleTitle |
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|